Women Health Diagnostics Market Major Manufacturers, Trends, Demand, Share Analysis to 2022

Latest Report on Women Health Diagnostics Market Global Analysis & 2022 Forecast Research Study

Pune, India - January 2, 2018 /MarketersMedia/ —

Global Women Health Diagnostics Industry

Market Insights
The Women Health Diagnostics market is projected to witness a steady growth rate of around 8% during the forecasted period 2016-2022. Rising prevalence of infectious diseases in women coupled with the increasing incidences of the chronic & lifestyle disorders are the key factors driving the global women health diagnostics market. The rise in prevalence of infectious diseases such as HIV in women across the globe has influenced the growth of health diagnostics market in women. According to World Health Organization, around 17.4 million women aged 15 and above were living with HIV in 2014 and this number increased to 17.8 million in 2015. Adolescent girls and young girls aged 15-24 are specifically affected by HIV worldwide. In 2015, around 2.3 million adolescent girls and young women were living with HIV which constitutes around 60% of all the young individuals living with HIV. Furthermore, increasing incidences of chronic disorders such as breast cancer have utmost impacted the rising need for health diagnostics in women. Breast Cancer is one of the most common cancer types among women at global level.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/1507773-global-women-health-diagnostics-market-research-and-analysis-2015-2022

Along with it, it is also the primary cause of death from cancer among women worldwide. As per Breast Cancer Research Foundation, breast cancer represents 1 in 4 of all cancers in women. Around 1 in 8 women in the U.S. is expected to develop invasive breast cancer during the course of her lifetime. And approx. 252,710 new cases of invasive breast cancer are projected to be diagnosed in women in United States in the year 2017. Such fact widens the scope for the growth of global women health diagnostics market. Apart from it, supportive government initiatives by government & health organizations and rising awareness about fertility tests have also played a vital role in the growth of the global market. However, lack of skilled laboratory personnel and high cost of procedures & diagnostic imaging systems are the key factors restraining the growth of this market.

Geographical Insights
The global Women Health Diagnostics market can be segregated geographically into Europe, North America, North America and RoW. In 2016, North America held the dominating position in the global women health diagnostics market. The growth of the regional market is backed by the increasing incidences of lifestyle related disorders and rising prevalence of cancer among women within the region. According to BREASTCANCER.ORG, around 40,610 women in the U.S. are projected to die in 2017 from breast cancer. In the U.S., breast cancer death rates in women are higher than those for any other cancer besides lung cancer. Along with it, as per American Cancer Society around 14,240 women have died due to ovarian cancer in the U.S. in 2016. Such fact specifies the high prevalence of cancer within the region which positively influences the demand for women health diagnostic products. Apart from it, rising demand for fertility testing monitors and growing focus of women health diagnostic product manufacturers on expanding their presence within the regional boundaries are also playing a vital role in the growth of the region.

Furthermore, Asia Pacific is the fastest growing region in the women health diagnostics market owing to the rising awareness among women related to several health disorders and increasing per capita income. Rising focus of international device manufacturers on strengthening their distribution networks within this region, epidemiological shift from the infectious diseases to chronic diseases within the regional boundaries and growing population within countries such as India and China are further boosting the growth of the women health diagnostics market in Asia Pacific.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Global Women Health Diagnostics market by region 2016

Source: OMR Analysis
Competitive Insights
The key players of Women Health Diagnostics market include Quest Diagnostics Inc., Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, GE Healthcare, Biomérieux SA and Koninklijke Philips N.V. Mergers and acquisitions, product launches, partnerships & collaborations and geographical expansion are some of the key strategies adopted by the market players to strengthen their KEY STRATEGY in the global market. On January 2017, Abbott Laboratories acquired St. Jude Medical Inc. (manufacturer of medical devices). The acquisition was valued around $25 billion. This strategic move is projected to strengthen Abbott’s leadership in global medical device market while offering products which in turn is projected to enhance its KEY STRATEGY in the women health diagnostic market.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/1507773-global-women-health-diagnostics-market-research-and-analysis-2015-2022
Market Segmentation:
o WOMEN HEALTH DIAGNOSTICS MARKET BY APPLICATION
§ BREAST CANCER TESTING
• BIOPSIES
• MAMMOGRAPHY
• BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS
• BREAST CANCER TUMOR MARKER TESTS
• OTHER DIAGNOSTIC IMAGING TESTS
§ CERVICAL CANCER TESTING
• HPV TESTING
• PAP SMEAR
§ OSTEOPOROSIS TESTING
• IN VITRO BLOOD TESTS
• BONE DENSITOMETRY
§ PREGNANCY & FERTILITY TESTING
• PREGNANCY TESTING & OVULATION PREDICTION KITS
• LAB-BASED TESTING
• FERTILITY MONITORS
§ OVARIAN CANCER TESTING
• DIAGNOSTIC IMAGING TESTS
• OVARIAN CANCER TUMOR MARKER TESTS
• OTHER TESTS
§ INFECTIOUS DISEASE TESTING
• URINARY TRACT INFECTION TESTING
• TUBERCULOSIS TESTING
• MRSA TESTING
• HEPATITIS TESTING
• OTHER INFECTIOUS DISEASE TESTING
§ PRENATAL GENETIC SCREENING AND CARRIER TESTING
• DOWN SYNDROME AND EDWARDS SYNDROME
• CYSTIC FIBROSIS
• TORCH INFECTIONS
• OTHER DISEASES
§ ULTRASOUND TESTS
• OB/GYN IMAGING
• BREAST IMAGING
§ SEXUALLY TRANSMITTED DISEASE TESTING
• HIV TESTING
• CT/NG (CHLAMYDIA TRACHOMATIS/NEISSERIA GONORRHOEAE) TESTING
• OTHER SEXUALLY TRANSMITTED DISEASES
o WOMEN HEALTH DIAGNOSTICS MARKET BY END USER
§ DIAGNOSTIC AND IMAGING CENTERS
§ HOSPITALS AND CLINICS
§ HOME CARE

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD

Source URL: https://marketersmedia.com/women-health-diagnostics-market-major-manufacturers-trends-demand-share-analysis-to-2022/282788

For more information, please visit https://www.wiseguyreports.com/sample-request/1507773-global-women-health-diagnostics-market-research-and-analysis-2015-2022

Source: MarketersMedia

Release ID: 282788